| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 67.143 | 90.646 | 146.992 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 68.064 | 92.725 | 147.827 |
| Total Expenses - EUR | - | - | - | - | - | - | 3.831 | 74.035 | 110.625 | 147.310 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -3.831 | -5.971 | -17.900 | 517 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -3.831 | -6.491 | -18.807 | 284 |
| Employees | - | - | - | - | - | - | 0 | 1 | 2 | 1 |
Check the financial reports for the company - Andiramar Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 16.442 | 11.517 |
| Current Assets | - | - | - | - | - | - | 7.141 | 41.072 | 60.187 | 55.127 |
| Inventories | - | - | - | - | - | - | 5.756 | 34.778 | 44.924 | 48.574 |
| Receivables | - | - | - | - | - | - | 1.010 | 3.755 | 11.297 | 0 |
| Cash | - | - | - | - | - | - | 375 | 2.539 | 3.966 | 6.554 |
| Shareholders Funds | - | - | - | - | - | - | -3.791 | -10.434 | -29.209 | -35.696 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 10.932 | 51.506 | 105.838 | 102.340 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Andiramar Medical S.r.l.